With a three-year, $1.6 million grant from the U.S. Department of Energy, the University of Nebraska–Lincoln’s Chi Zhang, ...

Study finds protein traits and CHO-cell gene programs drive therapeutic protein yields, guiding biomanufacturing.

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk ...

Eating before a workout helps fuel training sessions, while eating after a workout helps recovery. Fasted workouts may also ...

Routine liver function tests (LFTs) typically comprise alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, ...

Phase 1 data showed CRISPR’s one-time treatment, CTX310, produced sharp, dose-dependent reductions in triglycerides and LDL cholesterol with a strong safety profile. ・The company plans to advance the ...

A dding an investigational drug called clofutriben to corticosteroid therapy could make the latter less toxic in long-term ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

The time of eating influences the lipid metabolism in our body. A study conducted at the German Center for Diabetes Research (DZD) and the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) ...

A CRISPR-based gene therapy showed improvement in lipids in difficult-to-treat patients, but one study raised flags after a death last month in a trial of an unrelated gene therapy.

Researchers at the Universitat Oberta de Catalunya and the Institute of Photonic Sciences have created a Raman spectral ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) poses a significant challenge in modern medicine due to its high prevalence. The pathogenesis of MAFLD involves a complex dysmetabolic ...